TY - JOUR

T1 - Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa

T2 - results from a Cox proportional hazard regression analysis on disease progression amongst a cohort of 335 Danish patients with hidradenitis suppurativa

AU - Andersen, Rune Kjærsgaard

AU - Pedersen, Ole B.

AU - Eidsmo, Liv

AU - Jemec, Gregor B. E.

AU - Saunte, Ditte M. L.

N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PY - 2024/1/3

Y1 - 2024/1/3

N2 - BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory and scarring disease with a wide spectrum of disease severity. The amount of scaring is proportional to the preceding tissue damage and pose a challenge to patients. Severe HS is most often treatment recalcitrant, but hypothetically avoidable through early biologic treatment. Early prediction of individual risk of disease progression is therefore essential for patient management.OBJECTIVES: To investigate risk factors associated with disease progression and to design an algorithm capable of predicting disease progression.METHODS: A prospective cohort study of 335 patients without severe HS followed for a median of 2 years. Potential risk factors covered basic demographics, HS anamnestic factors and clinical HS factors collected during physical examination. Two separate Cox proportional hazard regression (CPHR) analyses were conducted. A summated "progression score" was calculated and used in the predictive algorithm of severe disease. Subsequent bootstrap sampling was used to validate the predictability of the predictive algorithm.RESULTS: The CPHR analysis of Transition to severe disease found that active smoking (HR = 4.01, 95% CI: 1.71-9.40, p = 0.001); BMI >25 at baseline (each point: HR = 1.06, 95% CI: 1.02-1.09, p < 0.001); active disease in 2 (HR = 4.26, 95% CI: 1.23-14.84, p = 0.02); and ≥3 areas (HR = 6.54, 95% CI: 1.89-22.72, p = 0.003) all constituted substantial risk factors. Conversely the CPHR analysis of Disease progression did not yield results of clinical relevance.A "progression score" of 3.04 was used as a threshold in the predictive algorithm of Transition to severe disease and achieved the following test specifics: sensitivity = 0.51, specificity = 0.86, positive predictive value = 0.50, negative predictive value = 0.86.CONCLUSIONS: We found a disparity between factors increasing the risk of simple Disease progression and those increasing the risk of Transition to severe disease. For the latter active smoking, BMI points >25, active disease in 2 or ≥3 areas all showed to be the clinically relevant factors that could be used to construct an algorithm that correctly predicted progression to severe HS in more than half of all instances.

AB - BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory and scarring disease with a wide spectrum of disease severity. The amount of scaring is proportional to the preceding tissue damage and pose a challenge to patients. Severe HS is most often treatment recalcitrant, but hypothetically avoidable through early biologic treatment. Early prediction of individual risk of disease progression is therefore essential for patient management.OBJECTIVES: To investigate risk factors associated with disease progression and to design an algorithm capable of predicting disease progression.METHODS: A prospective cohort study of 335 patients without severe HS followed for a median of 2 years. Potential risk factors covered basic demographics, HS anamnestic factors and clinical HS factors collected during physical examination. Two separate Cox proportional hazard regression (CPHR) analyses were conducted. A summated "progression score" was calculated and used in the predictive algorithm of severe disease. Subsequent bootstrap sampling was used to validate the predictability of the predictive algorithm.RESULTS: The CPHR analysis of Transition to severe disease found that active smoking (HR = 4.01, 95% CI: 1.71-9.40, p = 0.001); BMI >25 at baseline (each point: HR = 1.06, 95% CI: 1.02-1.09, p < 0.001); active disease in 2 (HR = 4.26, 95% CI: 1.23-14.84, p = 0.02); and ≥3 areas (HR = 6.54, 95% CI: 1.89-22.72, p = 0.003) all constituted substantial risk factors. Conversely the CPHR analysis of Disease progression did not yield results of clinical relevance.A "progression score" of 3.04 was used as a threshold in the predictive algorithm of Transition to severe disease and achieved the following test specifics: sensitivity = 0.51, specificity = 0.86, positive predictive value = 0.50, negative predictive value = 0.86.CONCLUSIONS: We found a disparity between factors increasing the risk of simple Disease progression and those increasing the risk of Transition to severe disease. For the latter active smoking, BMI points >25, active disease in 2 or ≥3 areas all showed to be the clinically relevant factors that could be used to construct an algorithm that correctly predicted progression to severe HS in more than half of all instances.

U2 - 10.1093/bjd/ljad530

DO - 10.1093/bjd/ljad530

M3 - Journal article

C2 - 38169316

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -